CDK4

E561032

CDK4 is a cyclin-dependent kinase that regulates cell cycle progression and is a key therapeutic target in certain cancers.

Try in SPARQL Jump to: Statements Referenced by

Statements (65)

Predicate Object
instanceOf cyclin-dependent kinase
human gene
protein kinase
alternativeName PSK-J3 NERFINISHED
cell division protein kinase 4 NERFINISHED
associatedWithDisease breast cancer
glioblastoma
liposarcoma
melanoma
non-small cell lung cancer NERFINISHED
biologicalProcess G1 phase of mitotic cell cycle
G1/S transition of mitotic cell cycle
cell cycle checkpoint regulation
negative regulation of cell cycle arrest
phosphorylation of RB1 protein
regulation of cell proliferation
cellularComponent cyclin-dependent protein kinase holoenzyme complex
cytoplasm
nucleus
chromosomalBand 12q14
clinicalBiomarkerRole predictive biomarker for CDK4/6 inhibitor response
conservedIn Danio rerio NERFINISHED
Mus musculus NERFINISHED
Rattus norvegicus NERFINISHED
encodedByGene CDK4 gene NERFINISHED
enzymeCommissionNumber EC 2.7.11.22
formsComplexWith cyclin D1
cyclin D2 NERFINISHED
cyclin D3
fullName cyclin-dependent kinase 4 NERFINISHED
geneType protein-coding gene
hasEnsemblGeneID ENSG00000135446
hasEntrezGeneID 1019
hasHGNCID HGNC:1773
hasUniProtID P11802
inhibitedByDrug abemaciclib NERFINISHED
lenvatinib (weak off-target)
palbociclib NERFINISHED
ribociclib NERFINISHED
trilaciclib NERFINISHED
locatedOnChromosome human chromosome 12
molecularFunction ATP binding
cyclin-dependent protein serine/threonine kinase activity
serine/threonine protein kinase activity
oncogenicMechanism activating mutation
gene amplification
overexpression
organism Homo sapiens
pathway G1/S transition pathway
cell cycle pathway
p16INK4A-CDK4-RB pathway
postTranslationalModification phosphorylation at threonine 172
regulatedBy CDKN2A (p16INK4A) NERFINISHED
CDKN2B (p15INK4B) NERFINISHED
CDKN2C (p18INK4C) NERFINISHED
CDKN2D (p19INK4D) NERFINISHED
requiresBindingPartner D-type cyclins
requiresCofactor Mg2+
roleInCancerBiology drives cell cycle progression from G1 to S phase
promotes tumor cell proliferation when deregulated
substrate RB1 NERFINISHED
RBL1 NERFINISHED
RBL2 NERFINISHED
therapeuticTargetIn advanced breast cancer
hormone receptor-positive breast cancer

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Verzenio targets CDK4